Vedanta Associates, L.p. - Net Worth and Insider Trading
Vedanta Associates, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Vedanta Associates, L.p. owns 1 companies in total, including Reviva Pharmaceuticals Holdings Inc (RVPH) .
Click here to see the complete history of Vedanta Associates, L.p.’s form 4 insider trades.
Insider Ownership Summary of Vedanta Associates, L.p.
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
RVPH | Reviva Pharmaceuticals Holdings Inc | 2021-06-01 | 10 percent owner |
Vedanta Associates, L.p. Trading Performance
Vedanta Associates, L.p. Ownership Network
Ownership Network List of Vedanta Associates, L.p.
Ownership Network Relation of Vedanta Associates, L.p.
Vedanta Associates, L.p. Owned Company Details
What does Reviva Pharmaceuticals Holdings Inc do?
Who are the key executives at Reviva Pharmaceuticals Holdings Inc?
Vedanta Associates, L.p. is the 10 percent owner of Reviva Pharmaceuticals Holdings Inc. Other key executives at Reviva Pharmaceuticals Holdings Inc include Chief Financial Officer Narayan Parbhu , director & 10 percent owner Parag Saxena , and 10 percent owner Vedanta Partners, Llc .
Reviva Pharmaceuticals Holdings Inc (RVPH) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Reviva Pharmaceuticals Holdings Inc (RVPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Reviva Pharmaceuticals Holdings Inc (RVPH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Reviva Pharmaceuticals Holdings Inc (RVPH)'s detailed insider trading history can be found in Insider Trading Tracker table.
Reviva Pharmaceuticals Holdings Inc Insider Transactions
Vedanta Associates, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Vedanta Associates, L.p.. You might contact Vedanta Associates, L.p. via mailing address: 250 West 55th Street, Suite 13d, New York Ny 10019.